Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Consultations on highly specialized medical treatments ongoing in Switzerland

The Swiss cantons are required to jointly draw up a plan for the provision of highly specialized medical treatments (MHS). It is up to the MHS decision-making body (which is part of the Conference of Cantonal Health Directors)  to determine which areas of care can be considered highly specialized medicine. The MHS decision-making body also decides on matters of planning and allocation of this type of care. These decisions result in the list of hospitals with highly specialized medicine. The planning of highly specialized medical treatments at the national level aims to provide economical care, adapted to needs, and of high quality.

The following areas of care are being discussed to enter the MHS, until September 17, 2020:

  • Partial areas of deep rectal resections and complex bariatric surgery (hospitals can already apply to become eligible to deliver this type of MHS)
  • Complex gynecological tumors
  • Pediatric oncology
  • Highly specialized pediatrics and pediatric surgery
  • Complex neurosurgery and neuroradiology (hospitals can already apply to become eligible to deliver this type of MHS)

Outcomes of this consultation is expected in early 2021.

See more details in French (switch to German in the top-right corner) here. See all other areas of care that will be discussed later in the year (some topics were postponed due to the COVID19 crisis) here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.